Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1106 hari yang lalu
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Sensex, Nifty End Choppy Session Little Changed

Sensex, Nifty End Choppy Session Little Changed

Indian shares fluctuated before ending little changed on Friday despite GST reforms optimism and firm cues from global markets amid growing expectations of a Federal Reserve interest-rate cut later this month.
RTTNews | 17j 18min yang lalu
European Shares Inch Higher In Cautious Trade

European Shares Inch Higher In Cautious Trade

European stocks were modestly higher on Friday as investors braced for the key U.S. jobs reading due later in the day and French Prime Minister Francois Bayrou's confidence vote on Monday.
RTTNews | 18j 31min yang lalu
Asian Shares Modestly Higher Before Pivotal US Jobs Report

Asian Shares Modestly Higher Before Pivotal US Jobs Report

Asian stocks eked out modest gains on Friday as weak U.S. labor market data reinforced expectations of a Federal Reserve rate cut later this month and U.S. President Donald Trump signed an executive order officially putting into action the U.S.-Japan trade agreement.
RTTNews | 19j 6min yang lalu
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The benchmark S&P/ASX 200 Index is gaining 30.30 points or 0.34 percent to 8,856.80, after touching a high of 8,880.70 earlier. The broader All Ordinaries Index is up 35.00 points or 0.39 percent to 9,126.40. Australian stocks closed significantly higher on Thursday.
RTTNews | 1 hari yang lalu
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian stock markets are trading mostly higher on Friday, following the broadly positive cues from Wall Street overnight, as some weaker than expected U.S. private sector job growth in the month of August bolstered bets the US Fed will lower interest rates later this month. The markets are pricing in a September rate cut and anticipating at least two reductions this year.
RTTNews | 1 hari yang lalu